Hello,

Back in May, the CDC released an interim statement about the possibility of neural tube defects in infants exposed to dolutegravir in utero. Here's the document: https://www.cdc.gov/hiv/pdf/basics/cdc-hiv-dolutegravir-alert.pdf

Since PEP is such a short course of therapy, the question is whether dolutegravir should be used in patients where pregnancy is only suspected (e.g. sexual assault victims, unprotected sex with someone whose HIV status is questionable, etc.)